PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA jennifer.e.miller@yale.edu.\', \'Equity Research and Innovation Center, Yale School of Medicine, New Haven, Connecticut, USA.\', \'Program for Biomedical Ethics, Yale School of Medicine, New Haven, Connecticut, USA.\', \'Yale Interdisciplinary Center for Bioethics, Yale School of Medicine, New Haven, Connecticut, USA.\', \'Philosophy, University of St Andrews, St Andrews, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e00801210.1136/bmjgh-2021-008012
?:hasPublicationType
?:journal
  • BMJ global health
is ?:pmid of
?:pmid
?:pmid
  • 35387769
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Ethical considerations in international clinical trial site selection.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35387769>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35387769>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all